Physician profile
Simran Gupta
NPI 1508432626
$2,364.96
in general payments reported to CMS, 2019-2025
11 companies · $1,474 in 2025
The $1,474 reported for 2025 was more than what 90% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $891 · 2025: $1,474.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,281 · Education: $84.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,280.96 |
| Education | $84.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $629.59 | 2024-2025 | Tremfya |
| Janssen Scientific Affairs, LLC | $510.79 | 2024-2025 | Tremfya |
| Genzyme Corporation | $375.41 | 2024-2025 | |
| Pentax of America, INC. | $214.13 | 2024 | Pentax Medical, C2 Cryoballoon, C2 Cryoballoon Focal Controller |
| Abbvie INC. | $188.10 | 2024-2025 | |
| Ipsen Biopharmaceuticals, INC | $139.10 | 2025 | Iqirvo |
| Evoke Pharma, INC. | $125.00 | 2024 | |
| Pfizer INC. | $94.40 | 2024-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $32.05 | 2025 | Entyvio |
| Mallinckrodt Hospital Products INC. | $31.51 | 2025 | Terlivaz |
| Exact Sciences Corporation | $24.88 | 2025 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Simran Gupta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.